Clin2
NCT07346469Possibly a fitNot yet recruiting

Magnesium for nerve health during colorectal cancer chemo

Colorectal Cancer (CRC)Chemotherapy Induced Peripheral Neuropathy (CIPN)Sleep QualityQuality of Life (QOL)

Part of Brain & nervous system, Cancer, Digestive system, Mental health clinical trials.

This trial tests if magnesium supplements can help reduce nerve damage (peripheral neuropathy) caused by chemotherapy. It also looks at how magnesium affects sleep and quality of life in people with colorectal cancer.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
75 people
Ages
20 years and older
Study type
Interventional

Who can take part

  • You have been diagnosed with colorectal cancer (confirmed by a biopsy).
  • You are at least 20 years old.
  • You are awake, alert, and able to communicate in Mandarin or Taiwanese.
  • You have either already received or are about to start chemotherapy with a drug called Oxaliplatin.
  • You do not have severe nerve damage, kidney problems, or other conditions listed as excluding factors.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06994507Recruiting· Phase 3
GM1 to prevent nerve damage from breast cancer chemo

This trial tests whether a drug called GM1 can prevent nerve damage (numbness, tingling, or pain in hands/feet) caused by a common chemotherapy drug used for breast cancer. If you are starting chemotherapy with nab-paclitaxel, this study may help protect your nerves.

Beijing
NCT07149649Recruiting· Phase 2/Phase 3
Magnesium for advanced lung cancer

This trial tests if adding magnesium supplements to standard first-line treatment (chemotherapy plus immunotherapy) improves outcomes for people with advanced non-small cell lung cancer (NSCLC) that has spread or cannot be removed by surgery. It is for patients who have not had prior treatment for metastatic disease.

Aarau
NCT06856447Recruiting· Phase 1
Coenzyme Q10 to prevent nerve damage from chemotherapy

This trial tests whether taking coenzyme Q10 (a natural substance) can help prevent nerve damage caused by the chemotherapy drug oxaliplatin in people with stage III colorectal cancer. If successful, it could reduce pain, numbness, or tingling during treatment.

Cairo
NCT05294367Recruiting· Early Phase 1
Magnesium by diet or skin lotion for people with lymphoma

This early study tests whether replacing magnesium—either by diet or a topical (skin) supplement—can improve safety or other health measures in people with lymphoma. It focuses on people who have a slightly low magnesium level and checks blood magnesium repeatedly during the study.

Rochester, Minnesota
NCT07504198Not yet recruiting· Phase 2/Phase 3
Memantine and rosuvastatin for nerve protection during chemo

This trial tests whether two common medications, memantine and rosuvastatin, can protect nerves during colorectal cancer treatment. If you are about to start chemotherapy with FOLFOX or XELOX, this study may help reduce nerve damage.

Tanta
NCT07626528Not yet recruiting· Early Phase 1
Wenyang Tongbi Formula for chemo nerve damage

This trial tests a traditional Chinese herbal medicine called Wenyang Tongbi Formula to treat nerve pain and weakness caused by chemotherapy. If you have breast or colorectal cancer and are experiencing chemotherapy-related nerve damage, this study may help manage your symptoms.

Beijing, Beijing Municipality

Hear when a new Colorectal Cancer (CRC) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.